BJL
BMRN icon

Brighton Jones LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Brighton Jones LLC’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
+27,779
New +$1.62M 0.03% 330
2025
Q4 		– Sell
-26,000
Closed -$1.41M – 161
2025
Q3 		$1.41M Buy
26,000
+5,520
+27% +$316K 0.03% 297
2025
Q2 		$1.13M Buy
+20,480
New +$1.21M 0.03% 297

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brighton Jones LLC's BMRN Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in BioMarin Pharmaceuticals (BMRN) in Q1 2026: 27,779 shares worth $1.57M. The stake represents 0.03% of the portfolio and ranks #330 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in BMRN as recently as Q3 2025.

Brighton Jones LLC first reported a position in BMRN in Q2 2025 and has held it in 3 quarters since. 556 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Brighton Jones LLC held 27,779 shares of BioMarin Pharmaceuticals worth $1.57M as of Q1 2026.
  • BioMarin Pharmaceuticals was a new Brighton Jones LLC position in Q1 2026.
  • BioMarin Pharmaceuticals made up 0.03% of Brighton Jones LLC's portfolio in Q1 2026, its #330 holding.
  • Brighton Jones LLC first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.